H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15. The firm’s 50 day simple moving average is $22.00 and its 200-day simple moving average is $22.00. The company has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- How to Start Investing in Real Estate
- AMD is Down 35%. Now is the Time to Buy the Dip
- Compound Interest and Why It Matters When Investing
- Amazon Stands Tall: New Highs Are in Sight
- What is the Shanghai Stock Exchange Composite Index?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
